Novitium Pharma is now part of ANI Pharmaceuticals. READ MORE > ANI Pharmaceuticals, Inc. ABOUT (CURRENT) PRODUCTS CONTRACT MANUFACTURING INVESTORS CAREERS CONTACT We are an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. FDA APPROVED Please see Indications and Important Safety Information and full Prescribing Information at Cortrophin.com. Visit website See press release US-CG-2100027 10/2021

ABOUT PRODUCTS CONTRACT MANUFACTURING INVESTORS CAREERS CONTACT INVESTOR RELATIONS Read More NASDAQ: ANIP 41.00 +0.57 ( 1.41% ) Pricing delayed by 20 minutes Last Updated 12/02/2021 4:00 PM OVERVIEW NEWSEVENTS & PRESENTATIONSSTOCK INFORMATION FINANCIALS GOVERNANCE RESOURCES SITE SEARCH CORPORATE OVERVIEW ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. Our strategy is to use our assets to develop, acquire, manufacture, and market branded and generic specialty prescription pharmaceuticals. By executing this strategy, we believe we will be able to continue to grow our business, expand and diversify our product portfolio, and create long-term value for our investors. LATEST NEWS 11/22/2021 ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses READ MORE 11/22/2021 ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 READ MORE 11/11/2021 ANI Pharmaceuticals Receives Clearance from U.S. Federal Trade Commission for the Acquisition of Novitium Pharma READ MORE VIEW ALL NEWS LATEST PRESENTATION 11/03/2021 ANI Pharmaceuticals Investor Presentation November 2021 DOWNLOAD PDF (OPENS IN NEW WINDOW) VIEW ALL PRESENTATIONS LATEST EVENTS 11/01/2021 ANI Pharmaceuticals, Inc. Third Quarter 2021 Earnings Call WEBCAST (OPENS IN NEW WINDOW) 09/30/2021 Cantor Virtual Global Healthcare Conference 2021 WEBCAST (OPENS IN NEW WINDOW) VIEW ALL EVENTS LATEST QUARTERLY REPORTS Q3 2021 Earnings Release Form 10-Q (OPENS IN NEW WINDOW) VIEW ALL FINANCIAL REPORTS CONTACT US INVESTOR CONTACT In-Site Communications, Inc. Lisa M. Wilson 212-452-2793 IR@anipharmaceuticals.com QUICK LINKS SEC FILINGS INVESTOR FAQS INFORMATION REQUEST FORM INVESTOR EMAIL ALERTS Email Address News Events & Presentations Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote SIGN UP UNSUBSCRIBE Products Investors Careers Contact Us Privacy Policy Terms of Use Accessibility © Copyright 2021 ANI Pharmaceuticals, Inc. follow us on linkedin follow us on youtube Powered By Q4 Inc. 5.66.0.1 (opens in new window)